CS 060380
Alternative Names: CS-060380Latest Information Update: 20 Sep 2024
Price :
$50 *
At a glance
- Originator Cascade Pharmaceuticals
- Class Hepatoprotectants; Small molecules
- Mechanism of Action Thyroid hormone receptor beta agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Non-alcoholic steatohepatitis
Most Recent Events
- 30 Aug 2024 Cascade Pharmaceuticals plans a phase I trial for Non-alcoholic steatohepatitis in China (NCT06573528)
- 27 Aug 2024 Preclinical trials in Non-alcoholic steatohepatitis in USA (PO) (Cascade Pharmaceuticals pipeline, August 2024)
- 13 Aug 2024 Pharmacodynamics data from preclinical studies in Non-alcoholic steatohepatitis released by Cascade Pharmaceuticals